Edge Medical

Edge Medical, founded in 2017 by two PhDs who studied at MIT and Harvard University, is a leading Chinese company in the research and manufacturing of intelligent surgical systems. It is committed to bringing the next generation of AI-powered minimally invasive surgical robot products with fully independent intellectual property rights into every surgical department. By redefining surgery through robotic technology, Edge Medical aims to make surgeries simpler and easier to perform, driving advancements in surgical procedures and improving medical experiences. The company's core team has interdisciplinary expertise in mechanics, electronics, artificial intelligence, medical imaging, and manufacturing, with extensive experience in R&D and industrialization. Edge Medical has developed three pipeline products: a single-port laparoscopic surgical robot system, a multi-port laparoscopic surgical robot system, and an ultra-high-definition 3D endoscope, all of which have entered the registration phase. The company has established extensive collaborations with several top-tier hospitals both domestically and internationally, including Harvard Medical School, the Chinese PLA General Hospital, and Sun Yat-sen University Affiliated Hospitals. Edge Medical owns a comprehensive intellectual property system, with over 200 patents applied for both domestically and internationally. It has been recognized as one of the "Top 20 Leading Biotech Companies in Shenzhen" and one of the "Top 50 Biotech Companies in the Guangdong-Hong Kong-Macao Greater Bay Area."